AR016561A1 - Polipeptido modificado; composiciones para la higiene, para la limpieza, para el cuidado de la piel y humectante de la piel; y gel para la ducha - Google Patents

Polipeptido modificado; composiciones para la higiene, para la limpieza, para el cuidado de la piel y humectante de la piel; y gel para la ducha

Info

Publication number
AR016561A1
AR016561A1 ARP980103756A ARP980103756A AR016561A1 AR 016561 A1 AR016561 A1 AR 016561A1 AR P980103756 A ARP980103756 A AR P980103756A AR P980103756 A ARP980103756 A AR P980103756A AR 016561 A1 AR016561 A1 AR 016561A1
Authority
AR
Argentina
Prior art keywords
enzyme
twin
skin
hygiene
cleaning
Prior art date
Application number
ARP980103756A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of AR016561A1 publication Critical patent/AR016561A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38627—Preparations containing enzymes, e.g. protease or amylase containing lipase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

El presente invento está referido a un polipéptido modificado que tiene un nivel de actividad enzimática superior a 70%, aproximadamente, del polipeptidooriginal y un nivel de respuesta alérgica inferior a 33% aproximadamente, del polipéptidoorigina l. Las realizaciones del presente invento están referidas apolipéptidos modificados con alergenicidad reducida y actividad enzimática elevada que comprenden la formula A-Bn, en donde A es una enzima y mezclas de ésta;B es una mitadpolimérica gemela, que tiene un peso molecular total de 0,5 kilodaltones (KD) a 40 KD, aproximadamente que tiene la formula R1R2X conjugada a laenzima; en donde R1 y R2 son esencialmente, polímeros de cadena recta que tienen un peso molecular quevaría de 0,25 KD a 20 KD; en donde la relacion de lospesos moleculares de R1 y R2 es de 1:10 a 10:1, aproximadamente, en donde X es una mitad de enlace que enlaza las mitades gemelas a un sitio individual de laenzima; y n es el numero de mitadespoliméricas gemelas conjun gadas a la enzima y representa un numero entero de 1 a 15, aproximadamente. El invento abarcatambién composiciones para la higiene, para la limpieza, para el cuidado de la piel y humectante de la piel y un gel para laducha, hechos con el aludidopoli péptido modificado.
ARP980103756A 1997-07-30 1998-07-30 Polipeptido modificado; composiciones para la higiene, para la limpieza, para el cuidado de la piel y humectante de la piel; y gel para la ducha AR016561A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/903,298 US6284246B1 (en) 1997-07-30 1997-07-30 Modified polypeptides with high activity and reduced allergenicity

Publications (1)

Publication Number Publication Date
AR016561A1 true AR016561A1 (es) 2001-07-25

Family

ID=25417259

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980103756A AR016561A1 (es) 1997-07-30 1998-07-30 Polipeptido modificado; composiciones para la higiene, para la limpieza, para el cuidado de la piel y humectante de la piel; y gel para la ducha

Country Status (12)

Country Link
US (1) US6284246B1 (es)
EP (1) EP1005373A1 (es)
JP (1) JP2001511461A (es)
KR (1) KR20010022419A (es)
CN (1) CN1268062A (es)
AR (1) AR016561A1 (es)
AU (1) AU8583498A (es)
BR (1) BR9811709A (es)
CA (1) CA2297437A1 (es)
CO (1) CO4810246A1 (es)
WO (1) WO1999006071A1 (es)
ZA (1) ZA986756B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US6495136B1 (en) * 1998-03-26 2002-12-17 The Procter & Gamble Company Proteases having modified amino acid sequences conjugated to addition moieties
US6458953B1 (en) * 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
CA2376057A1 (en) * 1999-06-08 2000-12-14 La Jolla Pharmaceutical Company Valency platform molecules comprising aminooxy groups
TW586945B (en) * 2001-01-12 2004-05-11 Novartis Ag Lens care product containing dexpanthenol
US20040007251A1 (en) * 2002-07-10 2004-01-15 Kimberly-Clark Worldwide, Inc. Cleaners for the control and removal of allergens
WO2004014973A2 (en) * 2002-08-13 2004-02-19 Sirus Pharmaceuticals Ltd Biodegradable polymer
US20070134335A1 (en) * 2005-06-08 2007-06-14 Lledo Ernest G Polypeptides with the capacity to entrap drugs and release them in a controlled way
RU2467015C2 (ru) 2005-10-05 2012-11-20 Коммонвелт Сайентифик Энд Индастриал Рисерч Организейшн Белки шелка
CA2771915C (en) 2009-08-26 2020-03-10 Commonwealth Scientific And Industrial Research Organisation Processes for producing silk dope
WO2013071356A1 (en) 2011-11-16 2013-05-23 Commonwealth Scientific And Industrial Research Organisation Collagen-like silk genes
CA2904749A1 (en) 2012-03-26 2013-10-03 Commonwealth Scientific And Industrial Research Organisation Silk polypeptides

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
DE2631656C2 (de) 1976-07-14 1983-02-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung eines Hydroxysuccinimidoester-Derivats zur Bindung von biologisch aktiven Proteinen aneinander und/oder an flüssige oder feste Trägerstoffe
US4556554A (en) 1981-06-01 1985-12-03 Germaine Monteil Cosmetiques Corp. Immobilized enzymes
US4760025A (en) 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
US5185258A (en) 1984-05-29 1993-02-09 Genencor International, Inc. Subtilisin mutants
EP0206448B1 (en) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4980288A (en) 1986-02-12 1990-12-25 Genex Corporation Subtilisin with increased thermal stability
ATE116365T1 (de) 1986-04-30 1995-01-15 Genencor Int Mutante einer nicht menschlichen carbonyl- hydrolase, für diese kodierende dns-sequenzen und vektoren und durch diese vektoren transformierte wirte.
JP2546807B2 (ja) * 1988-09-30 1996-10-23 鐘紡株式会社 化粧料
US5122614A (en) 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
GB8915658D0 (en) 1989-07-07 1989-08-23 Unilever Plc Enzymes,their production and use
US5030378A (en) 1990-01-02 1991-07-09 The Procter & Gamble Company Liquid detergents containing anionic surfactant, builder and proteolytic enzyme
US5133968A (en) 1990-08-20 1992-07-28 Kanebo, Ltd. Modified protease, method of producing the same and cosmetic products containing the modified protease
US5230891A (en) * 1990-08-20 1993-07-27 Kanebo Limited Modified protease, method of producing the same and cosmetic products containing the modified protease
ATE170630T1 (de) 1990-12-05 1998-09-15 Novo Nordisk As Proteine mit geänderten epitopen und verfahren zur deren herstellung
EP0516200B1 (en) 1991-05-01 1996-07-24 Unilever N.V. Detergent compositions containing stabilized enzymes
IT1260468B (it) 1992-01-29 1996-04-09 Metodo per mantenere l'attivita' di enzimi proteolitici modificati con polietilenglicole
GB9207280D0 (en) 1992-04-02 1992-05-13 Unilever Plc Skin care method and composition
GB9207288D0 (en) 1992-04-02 1992-05-13 Unilever Plc Cosmetic composition
US5470733A (en) 1993-06-01 1995-11-28 University Of Maryland Calcium free subtilisin mutants
US6436690B1 (en) 1993-09-15 2002-08-20 The Procter & Gamble Company BPN′ variants having decreased adsorption and increased hydrolysis wherein one or more loop regions are substituted
MA23346A1 (fr) 1993-10-14 1995-04-01 Genencor Int Variantes de la subtilisine
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5446090A (en) 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
ZA952220B (en) 1994-05-02 1995-12-14 Procter & Gamble Bpn' variants having decreased adsorption and increased hydrolysis wherein one or more loop regions are substituted
US6599730B1 (en) 1994-05-02 2003-07-29 Procter & Gamble Company Subtilisin 309 variants having decreased adsorption and increased hydrolysis
WO1996017929A1 (en) 1994-12-07 1996-06-13 Novo Nordisk A/S Polypeptide with reduced allergenicity
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
WO1996028475A1 (fr) 1995-03-10 1996-09-19 Nakamura, Toshikazu Facteur de croissance des hepatocytes modifie a l'aide de polyethylene glycol
AU5893696A (en) 1995-06-07 1996-12-30 Novo Nordisk A/S Modification of polypeptides
JPH11502256A (ja) * 1995-12-29 1999-02-23 ザ、プロクター、エンド、ギャンブル、カンパニー 固定化酵素を含有する洗剤組成物
US6159688A (en) 1997-03-18 2000-12-12 Novo Nordisk A/S Methods of producing polynucleotide variants

Also Published As

Publication number Publication date
EP1005373A1 (en) 2000-06-07
CN1268062A (zh) 2000-09-27
ZA986756B (en) 1999-02-10
KR20010022419A (ko) 2001-03-15
CA2297437A1 (en) 1999-02-11
BR9811709A (pt) 2000-07-25
JP2001511461A (ja) 2001-08-14
US6284246B1 (en) 2001-09-04
AU8583498A (en) 1999-02-22
CO4810246A1 (es) 1999-06-30
WO1999006071A1 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
AR016561A1 (es) Polipeptido modificado; composiciones para la higiene, para la limpieza, para el cuidado de la piel y humectante de la piel; y gel para la ducha
HRP20000436B1 (en) Erythropoietin derivatives
RS49533B (sr) Interferonski konjugati
ES2068999T3 (es) Composiciones para la liberacion retardada de clorhexidina.
ATE185578T1 (de) Thermoplastische und elastomere silikonpfropfcopolymere und diese enthaltende haar- und hautpflegemittel
PT749317E (pt) Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade
MEP19908A (en) Improved expression of cry3b insecticidal protein in plants
CY1111912T1 (el) Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων
OA09760A (fr) "Conjugués de protéine et de polyéthylène glycol".
DE69420142D1 (de) Thermoplastische Elastomere Copolymere und diese enthaltendes Haar und Hautflegemittel
FR2842209B1 (fr) Nouvelle protease aspartique dite saspase et son utilisation dans le domaine cosmetique et therapeutique
ATE273689T1 (de) Duftstoffvorläufer
BR0112962A (pt) Composições farmacêuticas para o tratamento de condições inflamatórias e ulcerativas dolorosas de maioria das superfìcies epiteliais tais como mucosite, estomatite e sìndrome de behcet
ATE286664T1 (de) Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung
FR2863867B1 (fr) Prothese interphalangienne et/ou metacarpophalangienne
TR199701521T1 (xx) Ya�s�z m�s�r �ipsleri.
ES2085249T1 (es) Una banda de enrejado.
KR910009241A (ko) 치근막 질환 치료용 서방성 조성물
ES2143180T3 (es) Composiciones farmaceuticas en forma de comprimidos de liberacion prolongada a base de granulados de polisacaridos de elevado peso molecular.
NO20010940L (no) TAN-1057 derivater
KR970032795A (ko) 요산 및 요산 분해 효소의 유효 함량을 함유하는 화장용 및 피부 관리용 조성물
BR0012694A (pt) Conjugado de protease, composição de limpeza e composição de tratamento pessoal
ATE307557T1 (de) Zubereitungen zur behandlung keratinischer fasern
BR0311479A (pt) Derivados de tiofeno antelmìnticos e inseticidas
ES2192064T3 (es) Composicion gelatinosa de pescado para usar como ingrediente en comprimidos.

Legal Events

Date Code Title Description
FB Suspension of granting procedure